Skip to main content

Supportive Care

Protocols

SCCRS

Cytokine Release Syndrome Management

SCDMAB

Treatment of Prostate Cancer Bone Metastases using Denosumab.

SCDRUGRX

Management of Infusion-Related Reactions to Systemic Therapy Agents

SCESA

Guidelines for the Use of Erythropoiesis-Stimulating Agents (ESAs) in Patients with Cancer.


SCHBV

Hepatitis B Virus Reactivation Prophylaxis

SCICANS

Management of Immune Effector Cell-Associated Neurotoxicity Syndrome 
Management of Immune-Mediated Adverse Reactions to Checkpoint Inhibitors Immunotherapy

SCMESNA

MESNA dosage modification for hematuria secondary to oxazaphosphorines (eg. Ifosfamide and Cyclophosphamide)

SCMMW

Treatment of Oral Mucositis Using BC Cancer Magic Mouthwash

SCNAUSEA

Antiemetic guidelines
Hyperlinks to PharmaCare:

SCOXRX

Inpatient protocol for Oxaliplatin Desensitization

SCPAINLI

Extreme Pain Therapy Using Parenteral Lidocaine

SCPAINSU

Incident pain therapy using sufentanil via sublingual route
Funding Algorithm

The funding algorithm provides information on what anti-cancer systemic therapy treatments are covered on the BC Cancer Benefit Drug List (formulary). It may not be a complete list of all treatment options that may be available and recommended by the treating physician.

Terms of use

The information contained in these documents is a statement of consensus of BC Cancer professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer's Terms of Use.

Tab Heading
SOURCE: Supportive Care ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2024 Provincial Health Services Authority